These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9462845)

  • 1. Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors.
    Schaschke N; Assfalg-Machleidt I; Machleidt W; Moroder L
    FEBS Lett; 1998 Jan; 421(1):80-2. PubMed ID: 9462845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aziridine analogs of [[trans-(epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as inhibitors of cysteine proteases.
    Martichonok V; Plouffe C; Storer AC; Ménard R; Jones JB
    J Med Chem; 1995 Aug; 38(16):3078-85. PubMed ID: 7636871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoxysuccinyl peptide-derived cathepsin B inhibitors: modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratin.
    Schaschke N; Deluca D; Assfalg-Machleidt I; Höhneke C; Sommerhoff CP; Machleidt W
    Biol Chem; 2002 May; 383(5):849-52. PubMed ID: 12108551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoxysuccinyl peptide-derived affinity labels for cathepsin B.
    Schaschke N; Assfalg-Machleidt I; Lassleben T; Sommerhoff CP; Moroder L; Machleidt W
    FEBS Lett; 2000 Sep; 482(1-2):91-6. PubMed ID: 11018529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.
    Barrett AJ; Kembhavi AA; Brown MA; Kirschke H; Knight CG; Tamai M; Hanada K
    Biochem J; 1982 Jan; 201(1):189-98. PubMed ID: 7044372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl group.
    Schaschke N; Assfalg-Machleidt I; Machleidt W; Turk D; Moroder L
    Bioorg Med Chem; 1997 Sep; 5(9):1789-97. PubMed ID: 9354234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
    Lalmanach G; Mayer R; Serveau C; Scharfstein J; Gauthier F
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):395-9. PubMed ID: 8809025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates.
    Portaro FC; Santos AB; Cezari MH; Juliano MA; Juliano L; Carmona E
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):123-9. PubMed ID: 10727410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miraziridine A: natures blueprint towards protease class-spanning inhibitors.
    Schaschke N
    Bioorg Med Chem Lett; 2004 Feb; 14(4):855-7. PubMed ID: 15012981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.
    Crawford C; Mason RW; Wikstrom P; Shaw E
    Biochem J; 1988 Aug; 253(3):751-8. PubMed ID: 2845932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides.
    Guay J; Falgueyret JP; Ducret A; Percival MD; Mancini JA
    Eur J Biochem; 2000 Oct; 267(20):6311-8. PubMed ID: 11012686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo.
    Towatari T; Nikawa T; Murata M; Yokoo C; Tamai M; Hanada K; Katunuma N
    FEBS Lett; 1991 Mar; 280(2):311-5. PubMed ID: 2013329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of noncovalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides.
    Chowdhury SF; Sivaraman J; Wang J; Devanathan G; Lachance P; Qi H; Ménard R; Lefebvre J; Konishi Y; Cygler M; Sulea T; Purisima EO
    J Med Chem; 2002 Nov; 45(24):5321-9. PubMed ID: 12431059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro.
    Murata M; Miyashita S; Yokoo C; Tamai M; Hanada K; Hatayama K; Towatari T; Nikawa T; Katunuma N
    FEBS Lett; 1991 Mar; 280(2):307-10. PubMed ID: 2013328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L.
    Estrada S; Pavlova A; Björk I
    Biochemistry; 1999 Jun; 38(22):7339-45. PubMed ID: 10353845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities.
    Therrien C; Lachance P; Sulea T; Purisima EO; Qi H; Ziomek E; Alvarez-Hernandez A; Roush WR; Ménard R
    Biochemistry; 2001 Mar; 40(9):2702-11. PubMed ID: 11258881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing of primed and unprimed sites of calpains: Design, synthesis and evaluation of epoxysuccinyl-peptide derivatives as selective inhibitors.
    Dókus LE; Menyhárd DK; Tantos Á; Hudecz F; Bánóczi Z
    Eur J Med Chem; 2014 Jul; 82():274-80. PubMed ID: 24915003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The slow-binding inhibition of cathepsin K by its propeptide.
    Billington CJ; Mason P; Magny MC; Mort JS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):924-9. PubMed ID: 11027570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-64 [L-trans-epoxysuccinyl-leucyl-amido(4-guanidino)butane] and related epoxides as inhibitors of cysteine proteinases.
    Barrett AJ; Kembhavi AA; Hanada K
    Acta Biol Med Ger; 1981; 40(10-11):1513-7. PubMed ID: 7044005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.